Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 608 | 60.2% |
| Consulting Fee | $529,689 | 173 | 22.7% |
| Travel and Lodging | $213,261 | 838 | 9.1% |
| Food and Beverage | $100,133 | 2,477 | 4.3% |
| Honoraria | $73,502 | 61 | 3.1% |
| Unspecified | $13,340 | 7 | 0.6% |
| Education | $787.74 | 27 | 0.0% |
| Gift | $40.59 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $425,478 | 615 | $0 (2024) |
| PFIZER INC. | $302,727 | 434 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $243,854 | 188 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $238,566 | 188 | $0 (2024) |
| GENZYME CORPORATION | $175,822 | 218 | $0 (2024) |
| Lilly USA, LLC | $158,469 | 387 | $0 (2024) |
| Amgen Inc. | $108,156 | 270 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $90,874 | 140 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $86,582 | 197 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $78,910 | 164 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $350,278 | 527 | Mallinckrodt Hospital Products Inc. ($120,549) |
| 2023 | $362,571 | 575 | AbbVie Inc. ($88,092) |
| 2022 | $332,038 | 546 | ABBVIE INC. ($76,176) |
| 2021 | $242,930 | 389 | AbbVie Inc. ($69,940) |
| 2020 | $191,060 | 258 | Boehringer Ingelheim Pharmaceuticals, Inc. ($33,295) |
| 2019 | $367,794 | 742 | AbbVie, Inc. ($108,011) |
| 2018 | $213,778 | 512 | PFIZER INC. ($53,369) |
| 2017 | $277,270 | 643 | PFIZER INC. ($134,824) |
All Payment Transactions
4,192 individual payment records from CMS Open Payments — Page 1 of 168
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Rheumatology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Immunology | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: Immunology | ||||||
| 12/11/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Analgesic | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $291.48 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $157.95 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $111.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | UCB, Inc. | Bimzelx (Biological) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $9,360 | 5 |
| ADALIMUMAB PFIZER CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
| TOFACITINIB RA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 276 | 645 | $94,506 | $56,390 |
| 2022 | 7 | 337 | 741 | $105,375 | $62,540 |
| 2021 | 3 | 256 | 653 | $103,100 | $66,423 |
| 2020 | 3 | 196 | 453 | $70,350 | $38,566 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 495 | $74,250 | $47,670 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 85 | $10,625 | $5,243 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,500 | $2,391 | 36.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 17 | $2,295 | $959.60 | 41.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 18 | 22 | $836.00 | $125.87 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 511 | $76,650 | $49,274 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 100 | $12,500 | $6,482 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $8,500 | $4,371 | 51.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 35 | $4,725 | $1,785 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,100 | $405.70 | 36.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 25 | 37 | $1,406 | $190.43 | 13.5% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2022 | 11 | 13 | $494.00 | $31.96 | 6.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 574 | $86,100 | $57,744 | 67.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $14,250 | $7,150 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 22 | $2,750 | $1,529 | 55.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 154 | 409 | $61,350 | $33,431 | 54.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $7,000 | $3,656 | 52.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 14 | 16 | $2,000 | $1,480 | 74.0% |
About Dr. Ara Dikranian, M.D
Dr. Ara Dikranian, M.D is a Specialist healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609962026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ara Dikranian, M.D has received a total of $2.3M in payments from pharmaceutical and medical device companies, with $350,278 received in 2024. These payments were reported across 4,192 transactions from 76 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.4M).
As a Medicare-enrolled provider, Dikranian has provided services to 1,065 Medicare beneficiaries, totaling 2,492 services with total Medicare billing of $223,919. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Rheumatology
- Location San Diego, CA
- Active Since 10/04/2006
- Last Updated 01/10/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1609962026
Products in Payments
- ACTHAR (Biological) $330,436
- RINVOQ (Biological) $210,844
- XELJANZ (Drug) $207,861
- OFEV (Drug) $173,779
- SAPHNELO (Biological) $91,187
- KEVZARA (Biological) $90,649
- TALTZ (Drug) $80,486
- BENLYSTA (Biological) $76,458
- Otezla (Drug) $73,108
- COSENTYX (Biological) $69,272
- KEVZARA (Drug) $67,503
- SKYRIZI (Biological) $57,058
- Rinvoq (Biological) $51,703
- KEVZARA SARILUMAB INJECTION (Biological) $51,642
- RAYOS (Drug) $50,714
- INFLECTRA (Biological) $49,733
- Humira (Biological) $40,283
- Enbrel (Biological) $33,882
- Actemra (Biological) $28,400
- TAVNEOS (Drug) $26,799
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in San Diego
Eli Meltzer, M.d, M.D
Specialist — Payments: $370,216
Mr. John Lane, M.d, M.D
Specialist — Payments: $249,148
Dr. Douglas Wu, Md Phd, MD PHD
Specialist — Payments: $220,803
Mr. Milton Erman, M.d, M.D
Specialist — Payments: $137,954
Richard Burns, M.d, M.D
Specialist — Payments: $81,707
Dr. Stephen Sobel, M.d, M.D
Specialist — Payments: $73,157